Publication: A case report of multiple intermittent urticaria after treatment of COVID-19 infection
2
Issued Date
2021-07-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-85110740251
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.104, No.7 (2021), 1214-1217
Suggested Citation
Naphat Bhumiratana, Thanan Supasiri, Nuntida Salakshna, Wilai Thanasarnaksorn A case report of multiple intermittent urticaria after treatment of COVID-19 infection. Journal of the Medical Association of Thailand. Vol.104, No.7 (2021), 1214-1217. doi:10.35755/jmedassocthai.2021.07.12420 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/78064
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A case report of multiple intermittent urticaria after treatment of COVID-19 infection
Other Contributor(s)
Abstract
The authors report a case of a 32-year-old Thai woman with a COVID-19 infection that presented with urticaria and angioedema with a pityriasis rosea (PR)-like rash at a private hospital in Thailand. She presented at the hospital with bloody nasal discharge and diarrhea but without fever, myalgia, or any respiratory symptoms. She complained of angioedema and PR-like lesions on the third day of the treatment. Urticarial rash appeared intermittently for four weeks after all medications were discontinued, during which the patient had no fever, no respiratory symptoms, or any other symptoms. However, the RT-PCR results for COVID-19 RNA were positive during the time that the urticarial symptoms persisted. The COVID-19 RNA became negative on the fourth day after the last urticarial episode. Urticarial rash may be a clue that the inflammatory process is activated by COVID-19 virus after the treatment is completed.